ℹ️
🇬🇧
Search
Search for people relevant for "Bone marrow"
Bone marrow
Person
Class
Person
Publication
Programmes
Export current view
prof. MUDr. Lukáš Smolej Ph.D.
Academic staff at Faculty of Medicine in Hradec Králové
1 class
327 publications
Class
class
Clinical Biochemistry and Hematology
FOP10019 |
Faculty of Medicine in Hradec Králové
Publications
publication
The role of microenvironment in chronic lymphocytic leukemia
2010 |
Faculty of Medicine in Hradec Králové
publication
Severe anemia caused by combination of autoimmune hemolysis, pure red cell aplasia and massive bone marrow infiltration in an elderly patient with chronic lymphocytic leukemia: successful treatment with rituximab
2010 |
Faculty of Medicine in Hradec Králové
publication
Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia
+1
2008 |
Faculty of Medicine in Hradec Králové
publication
Achievement of Bcl-2/IgH negativity in peripheral blood/bone marrow is associated with better clinical outcome in patients with follicular lymphoma
+1
2007 |
Faculty of Medicine in Hradec Králové
publication
Bone marrow/peripheral blood positivity of Bcl-2/IgH rearrangement in patients with follicular lymphoma before treatment has no prognostic significance
+1
2007 |
Faculty of Medicine in Hradec Králové
publication
Angiogenesis in the Bone Marrow of Patients with Chronic Lymphocytic Leukaemia
+1
2007 |
Faculty of Medicine in Hradec Králové
publication
Angiogenesis in the Bone Marrow of Patients with Chronic Lymphocytic Leukaemia
2007 |
Publication without faculty affiliation
publication
Bone marrow/peripheral blood positivity of Bcl-2/IgH rearrangement in patients with follicular lymphoma before treatment has no prognostic significance
2007 |
Publication without faculty affiliation
publication
Achievement of Bcl-2/IgH negativity in peripheral blood/bone marrow is associated with better clinical outcome in patients with follicular lymphoma
2007 |
Publication without faculty affiliation
publication
Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)
2023 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
Load more publications (317)
Loading network view...